Eupraxia Pharmaceuticals Inc (EPRX)

Apr 02, 2025

(EPRX) Stock Market Analysis (EPRX:CA) - news.stocktradersdaily.com

Apr 02, 2025

Mar 31, 2025

Eupraxia Pharmaceuticals (EPRX) Projected to Post Earnings on Monday - Defense World

Mar 31, 2025

Mar 24, 2025

When (EPRX) Moves Investors should Listen (EPRX:CA) - news.stocktradersdaily.com

Mar 24, 2025

Mar 23, 2025

Eupraxia Pharmaceuticals Reports Strong Q4 2024 Results and Operational Progress - MSN

Mar 23, 2025

Mar 22, 2025

Here's Why We're Watching Eupraxia Pharmaceuticals' (TSE:EPRX) Cash Burn Situation - Yahoo Finance

Mar 22, 2025

Mar 22, 2025

Learn to Evaluate (EPRX) using the Charts (EPRX:CA) - Stock Traders Daily

Mar 22, 2025

Mar 22, 2025

Eupraxia Pharmaceuticals files report with SEC By Investing.com - Investing.com South Africa

Mar 22, 2025

Mar 21, 2025

Eupraxia Pharmaceuticals files report with SEC - Investing.com India

Mar 21, 2025

Mar 20, 2025

Eupraxia Pharmaceuticals Reports Fourth Quarter 2024 Financial Results - Weekly Voice

Mar 20, 2025

Mar 20, 2025

Eupraxia Pharmaceuticals Reports Fourth Quarter 2024 Financial Results -March 20, 2025 at 05:38 pm EDT - MarketScreener

Mar 20, 2025

Mar 19, 2025

(EPRX) Equity Market Report (EPRX:CA) - Stock Traders Daily

Mar 19, 2025

Mar 18, 2025

Eupraxia Pharmaceuticals (NASDAQ:EPRX) Trading Down 1.7% – What’s Next? - Defense World

Mar 18, 2025

Mar 17, 2025

(EPRX) Optimized Trading Opportunities (EPRX:CA) - Stock Traders Daily

Mar 17, 2025

Mar 15, 2025

(EPRX) Proactive Strategies (EPRX:CA) - Stock Traders Daily

Mar 15, 2025

Mar 11, 2025

How to Take Advantage of moves in (EPRX) (EPRX:CA) - Stock Traders Daily

Mar 11, 2025

Mar 02, 2025

(EPRX) Daily Stock Insights (EPRX:CA) - Stock Traders Daily

Mar 02, 2025

Feb 27, 2025

(EPRX) Stock Evaluation Report (EPRX:CA) - Stock Traders Daily

Feb 27, 2025

Feb 25, 2025

Eupraxia Pharmaceuticals is undervalued, Research Capital says - Cantech Letter

Feb 25, 2025

Feb 25, 2025

Eupraxia reports progress in EoE drug trial with promising results By Investing.com - Investing.com Canada

Feb 25, 2025

Feb 25, 2025

Medicenna Therapeutics Corp. - Baystreet.ca

Feb 25, 2025

Feb 25, 2025

Dye & Durham Limited - Baystreet.ca

Feb 25, 2025

Feb 25, 2025

Eupraxia Pharmaceuticals Inc. - Baystreet.ca

Feb 25, 2025

Feb 25, 2025

Eupraxia Pharmaceuticals Shares Rise on Positive Drug Trial Data - MarketWatch

Feb 25, 2025

Feb 25, 2025

Eupraxia Pharmaceuticals Reports Latest Updates - Investing.com

Feb 25, 2025

Feb 25, 2025

Eupraxia Pharmaceuticals Reports Latest Updates By Investing.com - Investing.com South Africa

Feb 25, 2025

Feb 25, 2025

Eupraxia Pharmaceuticals Inc. Announces Additional Positive Clinical Data from its Ongoing RESOLVE Phase 1b/2a Trial Evaluating EP-104GI for Treatment of Eosinophilic Esophagitis - Marketscreener.com

Feb 25, 2025

Feb 25, 2025

Eupraxia Pharmaceuticals Reports Promising Trial Results for Eosinophilic Esophagitis Treatment - TipRanks

Feb 25, 2025

Feb 25, 2025

Eupraxia reports progress in EoE drug trial with promising results - Investing.com India

Feb 25, 2025

Feb 25, 2025

Eupraxia Pharmaceuticals Brief: Announcing "Positive" Data From RESOLVE Phase 1b/2a Trial Of EP-104GI For Treatment Of Eosinophilic Esophagitis - Marketscreener.com

Feb 25, 2025

Feb 25, 2025

Eupraxia Pharmaceuticals Announces Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis - The Globe and Mail

Feb 25, 2025

Feb 25, 2025

Eupraxia's EoE Drug Achieves 94% Reduction in Key Inflammatory Markers Without Steroid Side Effects - StockTitan

Feb 25, 2025

Feb 24, 2025

Eupraxia Pharmaceuticals (NASDAQ:EPRX) Research Coverage Started at Craig Hallum - Defense World

Feb 24, 2025

Feb 22, 2025

Craig-Hallum starts Eupraxia at Buy, sees ‘significant upside’ potential - Yahoo Finance

Feb 22, 2025

Feb 21, 2025

Craig-Hallum sets $12 target for Eupraxia stock, rates it a Buy - Investing.com Australia

Feb 21, 2025

Feb 21, 2025

Craig-Hallum sets $12 target for Eupraxia stock, rates it a Buy By Investing.com - Investing.com South Africa

Feb 21, 2025

Feb 21, 2025

Top Premarket Decliners -February 21, 2025 at 07:50 am EST - Marketscreener.com

Feb 21, 2025

Feb 20, 2025

Short Interest in Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Declines By 6.0% - Defense World

Feb 20, 2025

Feb 19, 2025

Propel Holdings Inc. - Baystreet.ca

Feb 19, 2025

Feb 19, 2025

Eupraxia Pharmaceuticals appoints new CFO By Investing.com - Investing.com Nigeria

Feb 19, 2025

Feb 18, 2025

EPRXEupraxia Pharmac Latest Stock News & Market Updates - Stock Titan

Feb 18, 2025

Feb 18, 2025

Exco Technologies Limited - Baystreet.ca

Feb 18, 2025

Feb 18, 2025

Eupraxia Appoints Alex Rothwell To Succeed Bruce Cousins As CFO - Nasdaq

Feb 18, 2025

Feb 18, 2025

Eupraxia Pharmaceuticals Announces CFO Succession - GuruFocus.com

Feb 18, 2025

Feb 18, 2025

Eupraxia Pharmaceuticals Announces CFO Succession Amid Strategic Advancements - TipRanks

Feb 18, 2025

Feb 18, 2025

Eupraxia Pharmaceuticals appoints new CFO - Investing.com

Feb 18, 2025